Rocket Pharmaceuticals Stock Price on December 21, 2024
| RCKT Stock | USD 11.56 0.21 1.85% |
Below is the normalized historical share price chart for Rocket Pharmaceuticals extending back to February 18, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Rocket Pharmaceuticals stands at 11.56, as last reported on the 22nd of December, with the highest price reaching 11.79 and the lowest price hitting 11.15 during the day.
If you're considering investing in Rocket Stock, it is important to understand the factors that can impact its price. Rocket Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of -0.23, which implies the firm had a -0.23% return per unit of risk over the last 3 months. Rocket Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Rocket Pharmaceuticals' Risk Adjusted Performance of (0.19), coefficient of variation of (392.93), and Variance of 11.65 to confirm the risk estimate we provide.
At this time, Rocket Pharmaceuticals' Total Stockholder Equity is comparatively stable compared to the past year. Common Stock Total Equity is likely to gain to about 778.8 K in 2024, whereas Capital Stock is likely to drop slightly above 724 K in 2024. . At this time, Rocket Pharmaceuticals' Price Book Value Ratio is comparatively stable compared to the past year. Price Earnings To Growth Ratio is likely to gain to 1.16 in 2024, whereas Price To Free Cash Flows Ratio is likely to drop (12.51) in 2024. Rocket Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 18th of February 2015 | 200 Day MA 20.2917 | 50 Day MA 15.1632 | Beta 1.089 |
Rocket |
Sharpe Ratio = -0.2263
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | RCKT |
Estimated Market Risk
| 3.39 actual daily | 30 70% of assets are more volatile |
Expected Return
| -0.77 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.23 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Rocket Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Rocket Pharmaceuticals by adding Rocket Pharmaceuticals to a well-diversified portfolio.
Price Book 3.7341 | Book Value 3.619 | Enterprise Value 1 B | Enterprise Value Ebitda (7.77) | Shares Float 71.1 M |
Rocket Pharmaceuticals Main Headline on 22nd of December 2024
Disposition of 57273 shares by Jonathan Schwartz of Rocket P... by Jonathan Schwartz
Filed transaction by Rocket Pharmaceuticals Officer See Remarks. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Rocket Pharmaceuticals Valuation on December 21, 2024
It is possible to determine the worth of Rocket Pharmaceuticals on a given historical date. On December 21, 2024 Rocket was worth 11.31 at the beginning of the trading date compared to the closed value of 11.56. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Rocket Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Rocket Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Rocket Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Rocket Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 11.31 | 11.79 | 11.15 | 11.56 | 2,866,639 | |
12/22/2024 | 11.31 | 11.79 | 11.15 | 11.56 | 0.00 |
| Backtest Rocket Pharmaceuticals | | | Rocket Pharmaceuticals History | | | Rocket Pharmaceuticals Valuation | Previous |
Rocket Pharmaceuticals Trading Date Momentum on December 21, 2024
| On December 22 2024 Rocket Pharmaceuticals was traded for 11.56 at the closing time. The top price for the day was 11.79 and the lowest listed price was 11.15 . There was no trading activity during the period 0.0. Lack of trading volume on December 22, 2024 did not cause price change. The trading delta at closing time against the current closing price is 2.16% . |
Rocket Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Rocket Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Rocket Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Rocket financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Rocket Pharmaceuticals Stock history
Rocket Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Rocket is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Rocket Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Rocket Pharmaceuticals stock prices may prove useful in developing a viable investing in Rocket Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 84 M | 88.2 M | |
| Net Loss | -199.7 M | -189.7 M |
Rocket Pharmaceuticals Quarterly Net Working Capital |
|
Rocket Pharmaceuticals Stock Technical Analysis
Rocket Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Rocket Pharmaceuticals Period Price Range
Low | December 22, 2024
| High |
0.00 | 0.00 |
Rocket Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Rocket Pharmaceuticals December 22, 2024 Market Strength
Market strength indicators help investors to evaluate how Rocket Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Rocket Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Rocket Pharmaceuticals stock market strength indicators, traders can identify Rocket Pharmaceuticals entry and exit signals to maximize returns
Rocket Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Rocket Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Rocket Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Rocket to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.19) | |||
| Jensen Alpha | (0.91) | |||
| Total Risk Alpha | (0.97) | |||
| Treynor Ratio | (0.55) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Rocket Stock Analysis
When running Rocket Pharmaceuticals' price analysis, check to measure Rocket Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rocket Pharmaceuticals is operating at the current time. Most of Rocket Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Rocket Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rocket Pharmaceuticals' price. Additionally, you may evaluate how the addition of Rocket Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.